Therapeutic effects of Chelidonium majus on ocular surface ınflammation and tear film homeostasis in a benzalkonium chloride–ınduced rat model of dry eye disease
International Ophthalmology · 03.03.2026 · 46 (1)
DOI: 10.1007/s10792-026-04021-x ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, online erschienen am 03.03.2026. Verfasst von Adem Unal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Konya Numune Hospital, Konya, Turkey. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Tears, Chelidonium majus, Plant Extracts. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Selçuk University Research Foundation.
Abstract (Originalsprache)
PURPOSE: Dry eye disease (DED) is a multifactorial ocular surface disorder characterized by tear film instability and chronic inflammation. Natural compounds with anti-inflammatory activity have therefore attracted increasing interest. Chelidonium majus (C. majus) latex contains bioactive alkaloids with proven anti-inflammatory properties; however, its potential role in DED has not yet been investigated. METHODS: Forty-six Wistar rats were randomized into six groups: Control, DED, Loteprednol etabonate (LE), and three C. majus latex dilutions (1/1, 1/10, 1/100). DED was induced by twice-daily instillation of 0.2% benzalkonium chloride (BAC) for 14 days. Following induction, LE or C. majus latex was administered according to group allocation; controls received vehicle. Tear volume (phenol red thread test), fluorescein corneal staining score (CSS), and Cochet-Bonnet esthesiometry were measured on days 0, 14, 21, and 28. On day 29, corneal tissues were analyzed by ELISA for TNF-α, IL-1β, IFN-γ, NF-κB, MMP-2, MMP-9, TIMP-2, AQP1, and AQP5, and underwent histopathological evaluation (H&E). Latex composition was characterized using LC-QTOF-MS. Statistical analysis included ANOVA with post hoc Tukey testing; p < 0.05 was considered significant. RESULTS: At week 2, the DED groups demonstrated reduced tear volume (2.13 ± 0.83 mm) and increased corneal staining scores (CSS) (4.63 ± 1.06). By week 4, tear secretion improved in the LE (4.38 ± 0.52 mm) and in the C. majus 1/1 (4.56 ± 0.56 mm), 1/10 (4.88 ± 0.52 mm), and 1/100 (4.56 ± 0.50 mm) groups, approaching values observed in the control group. CSS decreased markedly in the C. majus 1/10 (0.38 ± 0.52) and LE (1.13 ± 0.83) groups, whereas the DED group remained elevated (2.38 ± 0.52). Corneal sensitivity improved in the LE and C. majus 1/1 (3.44 ± 0.42 mm), 1/10 (3.75 ± 0.27 mm), and 1/100 (3.50 ± 0.46 mm) groups. Inflammatory cytokines and MMP-2/9 levels decreased significantly across treatment groups, with the most pronounced reductions observed in the C. majus 1/10 group. Histopathological analysis revealed better preservation of stromal architecture and reduced inflammatory infiltration in treated groups compared with the DED group. CONCLUSIONS: Chelidonium majus latex demonstrated significant anti-inflammatory and tissue-protective effects in this experimental model, supporting further investigation as a potential adjunctive approach in inflammatory DED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Konya Numune Hospital, Konya, Turkey.
- Faculty of Medicine, Department of Ophthalmology, Selcuk University, Konya, Turkey. draysebozkurtoflaz@yahoo.com.
- Faculty of Medicine, Department of Pharmacology, Selcuk University, Konya, Turkey.
- Faculty of Medicine, Department of Biochemistry, Selcuk University, Konya, Turkey.
- Faculty of Medicine, Department of Pathology, Selcuk University, Konya, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Botany, Selcuk University, Konya, Turkey.
Förderung
- Selçuk University Research Foundation
Zitieren
APA
Unal, A., Bozkurt Oflaz, A., Cetin, N., Yayla, M., Menevse, E., Celik, Z. E., Tugay, O., & Bozkurt, B. (2026). Therapeutic effects of Chelidonium majus on ocular surface ınflammation and tear film homeostasis in a benzalkonium chloride–ınduced rat model of dry eye disease. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04021-x
Vancouver
Unal A, Bozkurt Oflaz A, Cetin N, Yayla M, Menevse E, Celik ZE, et al. Therapeutic effects of Chelidonium majus on ocular surface ınflammation and tear film homeostasis in a benzalkonium chloride–ınduced rat model of dry eye disease. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04021-x
BibTeX
@article{Unal2026,
author = {Unal, Adem and Bozkurt Oflaz, Ayse and Cetin, Nihal and Yayla, Muhammed and Menevse, Esma and Celik, Zeliha Esin and Tugay, Osman and Bozkurt, Banu},
title = {Therapeutic effects of Chelidonium majus on ocular surface ınflammation and tear film homeostasis in a benzalkonium chloride–ınduced rat model of dry eye disease},
journal = {International Ophthalmology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10792-026-04021-x}
}
EUVIMED